Search Browse Earnings

Ventyx Biosciences, Inc. — SlamSEC

Ventyx Biosciences, Inc.

Nasdaq:VTYX

Pharmaceutical Preparations·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$207.8M

FY 2024

Net Income

-$193.0M

FY 2024

EPS (Diluted)

-$3.30

FY 2024

Stock Price

$14.00

+0.1%

2026-03-03

52W Range

$0.78 – $25.00

P/E Ratio

-4.2x

Market Cap

$999.0M

Cash

$51.6M

FY 2024

Total Debt

—

Net Cash

$51.6M

Enterprise Value

$947.4M

Debt / EBITDA

0.2x

FY 2024

EV / EBITDA

-4.6x

Employees

—